ExxonMobil to Release Fourth Quarter 2023 Financial Results
SPRING, Texas–(BUSINESS WIRE)–Exxon Mobil Corporation (NYSE: XOM) will release its fourth quarter 2023 financial results on Friday, February 2, 2024.... Read more.
Energy Transfer LP Announces Cash Distributions on Series E and I Preferred Units
Series C and D Preferred Units to be Redeemed as Previously Announced DALLAS–(BUSINESS WIRE)–Energy Transfer LP (“ET”) today announced the quarterly... Read more.
Core Scientific, Inc. Releases Webcast and Presentation with Updates on Chapter 11 Emergence
AUSTIN, Texas–(BUSINESS WIRE)–$CORZQ #bitcoin—Core Scientific, Inc. (OTC: CORZQ) (“Core Scientific” or “the Company”), a leader... Read more.
Eight-Year Data for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
Patients with previously untreated advanced or metastatic renal cell carcinoma treated with Opdivo plus Yervoy experienced a 28% reduction in the risk of death vs.... Read more.
Cushman & Wakefield to Release Fourth Quarter and Full Year 2023 Earnings on February 20
CHICAGO–(BUSINESS WIRE)–#cre–Cushman & Wakefield (NYSE: CWK) will release its fourth quarter and full year 2023 financial results after the... Read more.
Principal® CEO Dan Houston to Speak at 2024 Bank of America Financial Services Conference
DES MOINES, Iowa–(BUSINESS WIRE)–Principal Financial Group® (Nasdaq: PFG) announced today that Dan Houston, chairman, president, and chief executive... Read more.
Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Demonstrates Long-Term Survival Benefits After Four Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma
Opdivo in combination with CABOMETYX reduced the risk of death by 23% in the first-line treatment of advanced renal cell carcinoma vs. sunitinib Four-year results... Read more.
Independent Bank Group, Inc. Reports Fourth Quarter Financial Results and Declares Quarterly Dividend
MCKINNEY, Texas–(BUSINESS WIRE)–Independent Bank Group, Inc. (NASDAQ: IBTX) today announced net income of $14.9 million, or $0.36 per diluted share,... Read more.
Chatham Lodging Trust Announces 2023 Distribution Characterization
WEST PALM BEACH, Fla.–(BUSINESS WIRE)–Chatham Lodging Trust (NYSE: CLDT), a lodging real estate investment trust (REIT) that invests in upscale extended-stay... Read more.
Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Not intended for UK-, US- or Canada-based media Abstracts to be presented at the 2024 American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium... Read more.